Literature DB >> 19148656

[Rheumatoid arthritis. Target outcome for treatment].

D Aletaha1, J Smolen.   

Abstract

Rheumatoid arthritis is a chronic disabling disease that results in considerable loss of physical function in patients over time. The ultimate goal of therapy is remission, a clinical state with a highly variable definition in the literature. For the purpose of achieving the best patient outcome, it is important to maintain the lowest possible disease activity. Therefore, stringent remission criteria should be chosen, which will lead to the best possible prevention of structural and functional decline. Standardised intensive therapeutic strategies and algorithms should form the basis for the administration of anti-rheumatic medication.

Entities:  

Mesh:

Year:  2009        PMID: 19148656     DOI: 10.1007/s00393-008-0357-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  12 in total

1.  The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.

Authors:  P M Welsing; A M van Gestel; H L Swinkels; L A Kiemeney; P L van Riel
Journal:  Arthritis Rheum       Date:  2001-09

2.  Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.

Authors:  D M van der Heijde; M A van't Hof; P L van Riel; M A van Leeuwen; M H van Rijswijk; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 3.  Bone destruction in arthritis.

Authors:  E M Gravallese
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

4.  Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system.

Authors:  M A van Leeuwen; M H van Rijswijk; W J Sluiter; P L van Riel; I H Kuper; L B van de Putte; M B Pepys; P C Limburg
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

5.  Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time.

Authors:  K W Drossaers-Bakker; M de Buck; D van Zeben; A H Zwinderman; F C Breedveld; J M Hazes
Journal:  Arthritis Rheum       Date:  1999-09

6.  Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.

Authors:  J S Smolen; C Han; D M F M van der Heijde; P Emery; J M Bathon; E Keystone; R N Maini; J R Kalden; D Aletaha; D Baker; J Han; M Bala; E W St Clair
Journal:  Ann Rheum Dis       Date:  2008-07-01       Impact factor: 19.103

7.  American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

Authors:  D T Felson; J J Anderson; M Boers; C Bombardier; D Furst; C Goldsmith; L M Katz; R Lightfoot; H Paulus; V Strand
Journal:  Arthritis Rheum       Date:  1995-06

8.  The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

Authors:  D T Felson; J J Anderson; M Boers; C Bombardier; M Chernoff; B Fried; D Furst; C Goldsmith; S Kieszak; R Lightfoot
Journal:  Arthritis Rheum       Date:  1993-06

9.  Assessing remission in clinical practice.

Authors:  M Mierau; M Schoels; G Gonda; J Fuchs; D Aletaha; J S Smolen
Journal:  Rheumatology (Oxford)       Date:  2007-03-06       Impact factor: 7.580

10.  Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.

Authors:  Daniel Aletaha; Valerie P K Nell; Tanja Stamm; Martin Uffmann; Stephan Pflugbeil; Klaus Machold; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2005-04-07       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.